InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by C.P. Riedl. Director active across 1 companies, notably Vivoryon Therapeutics N.V.. Cumulatively, 4 reports have been published. The latest transaction was filed on 30 June 2025 — Purchase. Regulator: AFM. The full history is openly available.
Declarations4 total
025,000 shares0
Optie
AFM:176908·
Ideal exit: 27 Mar 2026 (T+270)
025,000 shares0
Optie
AFM:160247·
Ideal exit: 18 Mar 2025 (T+270)
090,000 shares0
Optie
AFM:144123·
Ideal exit: 19 Mar 2023 (T+270)
01,000 shares0
Gewoon aandeel
AFM:145240·
Ideal exit: 19 Mar 2023 (T+270)
4 of 4 declarations
